Clovis Oncology's GAAP loss for three months of 2021 was $66.277 million, down 33.3% from $99.332 million in the prior year. Revenue decreased 10.6% to $38.053 million from $42.564 million a year earlier.
Clovis Oncology's GAAP loss for three months of 2021 was $66.277 million, down 33.3% from $99.332 million in the prior year. Revenue decreased 10.6% to $38.053 million from $42.564 million a year earlier. 
ir.clovisoncology.com
English (US) 